Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Langue: | |
| Publié: |
Zenodo
2026
|
| Accès en ligne: | https://doi.org/10.5281/zenodo.20244914 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Table des matières:
- <p>We measured total transcription by RNA-sequencing in patients sensitive or resistant to treatment with trastuzumab for HER2+ breast cancer for discovery of genes that confer or support resistance to HER2-targeted therapies in humans. In this manuscript we describe identification of Ccl19 as a candidate gene product of the trastuzumab resistance gene expression signature. </p>